AdaptHealth Corp. (NASDAQ: AHCO) has a higher price-to-earnings ratio of 29.48x compared to its average ratio. compared to its average ratio and a 36-month beta value of 0.69. Analysts have mixed views on the stock, with 9 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price point forecasted by analysts for AdaptHealth Corp. (AHCO) is $22.40, which is $9.57 above the current market price. The public float for AHCO is 88.31M, and currently, short sellers hold a 10.81% ratio of that float. The average trading volume of AHCO on March 16, 2023 was 1.03M shares.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
AHCO) stock’s latest price update
AdaptHealth Corp. (NASDAQ: AHCO)’s stock price has increased by 1.96 compared to its previous closing price of 13.27. but the company has seen a -9.44% decline in its stock price over the last five trading sessions.
AHCO’s Market Performance
AHCO’s stock has fallen by -9.44% in the past week, with a monthly drop of -36.09% and a quarterly drop of -38.56%. The volatility ratio for the week is 6.06% while the volatility levels for the last 30 days are 4.75% for AdaptHealth Corp. The simple moving average for the last 20 days is -25.10% for AHCO stock, with a simple moving average of -33.04% for the last 200 days.
Analysts’ Opinion of AHCO
Many brokerage firms have already submitted their reports for AHCO stocks, with SVB Leerink repeating the rating for AHCO by listing it as a “Outperform.” The predicted price for AHCO in the upcoming period, according to SVB Leerink is $30 based on the research report published on September 27th of the previous year 2021.
Robert W. Baird, on the other hand, stated in their research note that they expect to see AHCO reach a price target of $36, previously predicting the price at $30. The rating they have provided for AHCO stocks is “Outperform” according to the report published on July 14th, 2021.
AHCO Trading at -31.23% from the 50-Day Moving Average
After a stumble in the market that brought AHCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.76% of loss for the given period.
Volatility was left at 4.75%, however, over the last 30 days, the volatility rate increased by 6.06%, as shares sank -35.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.60% lower at present.
During the last 5 trading sessions, AHCO fell by -9.44%, which changed the moving average for the period of 200-days by -23.82% in comparison to the 20-day moving average, which settled at $17.69. In addition, AdaptHealth Corp. saw -29.60% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at AHCO starting from Everest Hill Group Inc., who sale 540,000 shares at the price of $20.75 back on Feb 06. After this action, Everest Hill Group Inc. now owns 12,805,008 shares of AdaptHealth Corp., valued at $11,205,007 using the latest closing price.
Everest Hill Group Inc., the 9.9% owner of AdaptHealth Corp., sale 44,789 shares at $21.00 during a trade that took place back on Feb 01, which means that Everest Hill Group Inc. is holding 13,345,008 shares at $940,569 based on the most recent closing price.
Stock Fundamentals for AHCO
Equity return is now at value 3.00, with 1.20 for asset returns.
To put it simply, AdaptHealth Corp. (AHCO) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.